UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 130

Sortiert nach

Response to Canadian Psychiatric Association Cannabinoid Products Position Statement: Potential for Ameliorating Cannabis Withdrawal

Canadian journal of psychiatry, 2021-06, Vol.66 (6), p.586-587

Bahji, Anees

2021

Link zum Volltext

Verfügbarkeit prüfen

Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review

Journal of clinical medicine, 2024-02, Vol.13 (4), p.999

Bahji, Anees

2024

Link zum Volltext

Verfügbarkeit prüfen

Guilty until proven innocent

Canadian medical education journal, 2023-11, Vol.14 (5), p.149-149

Bahji, Anees

2023

Link zum Volltext

Verfügbarkeit prüfen

The Emerging Epidemic of Male Me-Too: Response to Men’s Mental Health: Beyond Victim Blaming

Canadian journal of psychiatry, 2018-12, Vol.63 (12), p.852-852

Bahji, Anees

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis

Journal of affective disorders, 2021-01, Vol.278, p.542-555

2021

Link zum Volltext

Verfügbarkeit prüfen

Psychotherapies for Adolescents with Subclinical and Borderline Personality Disorder: A Systematic Review and Meta-Analysis

Canadian journal of psychiatry, 2020-01, Vol.65 (1), p.5-15

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis

Journal of affective disorders, 2020-05, Vol.269, p.154-184

2020

Link zum Volltext

Verfügbarkeit prüfen

Response to Canadian Psychiatric Association Opioid Use Disorder Position Statement: More than Just Collaborators in Care

Canadian journal of psychiatry, 2021-03, Vol.66 (3), p.321-322

2021

Link zum Volltext

Verfügbarkeit prüfen

Systematic Review and Meta-Analyses of Psychotherapies for Adolescents with Subclinical and Borderline Personality Disorder: A Reply to the Commentary by Jørgensen, Storebø, and Simonsen

Canadian journal of psychiatry, 2020-05, Vol.65 (5), p.356-357

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium

Journal of Psychopharmacology, 2021-08, Vol.35 (8), p.890-900

2021

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 and the Need for Leadership Training in Psychiatry

Canadian journal of psychiatry, 2021-01, Vol.66 (1), p.65-66

2021

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis

Canadian journal of psychiatry, 2020-06, Vol.65 (6), p.365-376

2020

Link zum Volltext

Verfügbarkeit prüfen

Ways to get a more balanced gender representation in addiction journals’ management and workforce

Nordisk alkohol- & narkotikatidskrift : NAT, 2023-12, Vol.40 (6), p.560-567

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis

BMC geriatrics, 2022-07, Vol.22 (1), p.601-601, Article 601

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis

Canadian journal of psychiatry, 2021-03, Vol.66 (3), p.274-288

2021

Link zum Volltext

Verfügbarkeit prüfen

Training in Substance Use Disorders, Part 2: Updated Curriculum Guidelines

Canadian journal of psychiatry, 2024-06, Vol.69 (6), p.457-478

2024

Link zum Volltext

Verfügbarkeit prüfen

Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations

Canadian journal of psychiatry, 2024-06, Vol.69 (6), p.428-456

2024

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Community Treatment Orders on Substitute Decision Makers

Canadian journal of psychiatry, 2021-01, Vol.66 (1), p.64-65

2021

Link zum Volltext

Verfügbarkeit prüfen

The critical role of peer reviewers: Challenges and future steps

Nordisk alkohol- & narkotikatidskrift : NAT, 2023-02, Vol.40 (1), p.14-21

2023

Link zum Volltext

Verfügbarkeit prüfen

Gaps in Psychiatric Training Could Challenge Delivery of Optimal Schizophrenia Pharmacotherapy

Canadian journal of psychiatry, 2018-02, Vol.63 (2), p.146-147

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis

Journal of Psychopharmacology, 2023-02, Vol.37 (2), p.135-143

2023

Link zum Volltext

Verfügbarkeit prüfen

The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial

Canadian journal of psychiatry, 2024-03, Vol.69 (3), p.172-182

2024

Link zum Volltext

Verfügbarkeit prüfen

Exclusion of the non-English-speaking world from the scientific literature: Recommendations for change for addiction journals and publishers

Nordisk alkohol- & narkotikatidskrift : NAT, 2023-02, Vol.40 (1), p.6-13

2023

Link zum Volltext

Verfügbarkeit prüfen

Listening to the Patient's Voice: A Patient-Centred Approach to Treatment-Resistant Schizophrenia

Canadian journal of psychiatry, 2022-03, Vol.67 (3), p.235-237

2022

Link zum Volltext

Verfügbarkeit prüfen

The Rising Tide of Stimulant-Related Morbidity and Mortality Warrants Evidence-Based Treatment

Canadian journal of psychiatry, 2023-03, Vol.68 (3), p.208-209

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(115)

Publikationsform

Artikel
(130)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Response to Canadian Psychiatric Association Cannabinoid Products Position Statement: Potential for Ameliorating Cannabis Withdrawal

Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review

Guilty until proven innocent

The Emerging Epidemic of Male Me-Too: Response to Men’s Mental Health: Beyond Victim Blaming

Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis

Psychotherapies for Adolescents with Subclinical and Borderline Personality Disorder: A Systematic Review and Meta-Analysis

Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis

Response to Canadian Psychiatric Association Opioid Use Disorder Position Statement: More than Just Collaborators in Care

Systematic Review and Meta-Analyses of Psychotherapies for Adolescents with Subclinical and Borderline Personality Disorder: A Reply to the Commentary by Jørgensen, Storebø, and Simonsen

Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium

COVID-19 and the Need for Leadership Training in Psychiatry

Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis

Ways to get a more balanced gender representation in addiction journals’ management and workforce

Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis

Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis

Training in Substance Use Disorders, Part 2: Updated Curriculum Guidelines

Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations

The Impact of Community Treatment Orders on Substitute Decision Makers

The critical role of peer reviewers: Challenges and future steps

Gaps in Psychiatric Training Could Challenge Delivery of Optimal Schizophrenia Pharmacotherapy

Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis

The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial

Exclusion of the non-English-speaking world from the scientific literature: Recommendations for change for addiction journals and publishers

Listening to the Patient's Voice: A Patient-Centred Approach to Treatment-Resistant Schizophrenia

The Rising Tide of Stimulant-Related Morbidity and Mortality Warrants Evidence-Based Treatment

Suchergebnisse filtern